170 related articles for article (PubMed ID: 16474166)
1. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
Chakraborty G; Rangaswami H; Jain S; Kundu GC
J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
Mahabeleshwar GH; Das R; Kundu GC
J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Dec; 278(52):52598-612. PubMed ID: 14534291
[TBL] [Abstract][Full Text] [Related]
4. JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2005 May; 280(19):19381-92. PubMed ID: 15757900
[TBL] [Abstract][Full Text] [Related]
5. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
[TBL] [Abstract][Full Text] [Related]
7. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.
Walk SF; March ME; Ravichandran KS
Eur J Immunol; 1998 Aug; 28(8):2265-75. PubMed ID: 9710204
[TBL] [Abstract][Full Text] [Related]
8. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
10. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
11. Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes.
Jiang Y; Cheng H
Leuk Res; 2007 Apr; 31(4):541-5. PubMed ID: 16938345
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
13. bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.
Trisciuoglio D; Iervolino A; Candiloro A; Fibbi G; Fanciulli M; Zangemeister-Wittke U; Zupi G; Del Bufalo D
J Biol Chem; 2004 Feb; 279(8):6737-45. PubMed ID: 14660675
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis.
Mishra R; Thorat D; Soundararajan G; Pradhan SJ; Chakraborty G; Lohite K; Karnik S; Kundu GC
Oncogene; 2015 Mar; 34(12):1584-95. PubMed ID: 24727891
[TBL] [Abstract][Full Text] [Related]
15. Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells.
Zhang X; Shrikhande U; Alicie BM; Zhou Q; Geahlen RL
Mol Cancer Res; 2009 May; 7(5):634-44. PubMed ID: 19435818
[TBL] [Abstract][Full Text] [Related]
16. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk.
Williams S; Couture C; Gilman J; Jascur T; Deckert M; Altman A; Mustelin T
Eur J Biochem; 1997 Apr; 245(1):84-90. PubMed ID: 9128727
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
20. The Syk protein tyrosine kinase can function independently of CD45 or Lck in T cell antigen receptor signaling.
Chu DH; Spits H; Peyron JF; Rowley RB; Bolen JB; Weiss A
EMBO J; 1996 Nov; 15(22):6251-61. PubMed ID: 8947048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
